Indivior (LON:INDV) Stock Price Down 15.7% – Here’s Why

Shares of Indivior PLC (LON:INDV) dropped 15.7% on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 732 ($9.25). Approximately 1,888,371 shares changed hands during mid-day trading, an increase of 166% from the average daily volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Ratings Changes

Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 1,800 ($22.74) price objective on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Stock Down 5.9 %

The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The company has a market capitalization of £1.08 billion, a P/E ratio of -570.87, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a 50-day moving average of GBX 920.11 and a two-hundred day moving average of GBX 850.81.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.